US$ 22.77
dpp 4 inhibitor glp 1 agonist GLP-1 Receptor Agonists Have better Outcomes Than DPP4 Inhibitors in T2D patients & CKD How do SGLT-2 inhibitors, GLP-1
Description
GLP-1 agonists, which primarily target extrahepatic mechanisms to ameliorate metabolic disorders, when used in conjunction with resmetirom, focusing on intrahepatic mechanisms, offer a complementary approach in the management of MASH and liver fibrosis
Metformin belongs to a drug class called biguanides

PMID: 60 SontamTChenHRamanJChenAChoSWTarboxM

It is marketed there under the brand name Lirasen

[DOI] [PubMed] [Google Scholar] 229.Yun S.P., Kam T.I., Panicker N., Kim S., Oh Y., Park J.S
